Theralase Technologies Inc. V.TLT

The objective of the newsletter

[ScienceFirst]

The newsletter is a marketing vhicule to give more latitude to the management to communicate, in an informal way, additional information than just financial data.

[fredgoodwinson]

A Company is required to release price-sensitive information in a timely manner to enable informed investment decisions to be made and thus ensure an orderly market in their Stock. It is not a question of whether a Management considers it optional - or might think that they are doing their Shareholders a favour - if they tell them anything beyond the figures in the Financial Statements. It is

[ScienceFirst]

They can release a news pouring to the newsletter that would contain clinical data update, without financial data, like they did on April 27, 2021: Theralase Releases Quarterly Newsletter Toronto, Ontario – April 27, 2021, Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research and

[ScienceFirst]

... "pointing" ... not ... "pouring"! They can release a news pointing to the newsletter that would contain clinical data update, without financial data, like they did on April 27, 2021: Theralase Releases Quarterly Newsletter Toronto, Ontario – April 27, 2021, Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical

[fredgoodwinson]

That`s right Science First there`s no requirement for financial data to accompany the Newsletter and to the best of my knowledge it never has and probably shouldn`t. Was using the example of Australia where both News and Financials are required and where with the further interim update between the end of the Quarter and the announcement itself the retail Shareholder is effectively never further

[99942Apophis]

Let's look at patient 30, all we know is that was the last patient announced Nov 29. If that patient #30 was treated a couple of days prior to the Newsletter then to hit 90 days I could be wrong its 90 days plus or minus 7. For that reason when I gave my spread of early to late time frame it had to extend to week of March 7 with that Friday of the 11th. Do we also take into consideration where

[fredgoodwinson]

No that makes sense 99942 but this whole Newsletter thing is entirely self-inflicted and in no way precludes a quite separate announcement of the Clinical Trial results. For someone who for the last 5 years+ has been very interested in what Rutherrin might do and for the last 18 months+ even more so in the knowledge that it can be activated extra-corporeally by x-ray there`s plenty that a

[Infinity]

Agreed, Fred. It is simply good business practice to keep the stake holders informed of any developments, even if is just a short update on 1. Results vs Goals, 2. Major Opportunities vs Challenges 3. Short and Longterm plans with specific timelines and overall health of the company. It is simple and straight forward transperancy that should be integral to the core values of any company.

[Gooseybear]

Agreed with the need for basic information any reasonable company must provide. I wonder how often the Board meets and the type of information they are provided.